Withings has introduced a new health tech device at CES this year, the BeamO, priced at $249.95. BeamO is a…
Browsing: Hot headlines in GI
In November, Blue Cross Blue Shield Massachusetts announced that beginning Jan. 1, it would no longer cover the use of…
The current approach to esophageal function testing is deemed insufficient for accurately characterizing esophageal motility disorders, particularly in patients with…
Gastroenterologists working at physician-owned entities outearn their hospital and management service counterparts, according to Healthcare Appraisers’ 2023 GI “Industry Outlook”…
A phase 1 trial for a vaccine targeting micrometastatic disease markers in patients treated for pancreatic or colorectal cancer has…
The incidence of colorectal cancer (CRC) has been steadily increasing among men younger than 50 years, while remaining stable among…
Scientists have developed a groundbreaking test that can detect 18 early-stage cancers, potentially representing a significant advancement in medical diagnostics.…
Cutting out coinsurance for patients undergoing colonoscopy after a positive stool test could improve patient life-years, according to new research.…
Robotic surgery is associated with improved outcomes over laparoscopic procedures for colon cancer patients undergoing colectomies, according to a new…
Eli Lilly, the pharmaceutical company behind the anti-obesity drug Zepbound, has launched LillyDirect, a direct-to-patient portal. This innovative platform allows…